Atwood J. Management of Acute Coronary Syndrome. Emerg Med Clin North Am. 2022;40(4):693–706. https://doi.org/10.1016/j.emc.2022.06.008.
Yang EH, Brilakis ES, Reeder GS, Gersh BJ. Modern management of acute myocardial infarction. Curr Probl Cardiol. 2006;31(12):769–817. https://doi.org/10.1016/j.cpcardiol.2006.08.004.
Jiménez-Méndez C, Díez-Villanueva P, Alfonso F. Non-ST segment elevation myocardial infarction in the elderly. Rev Cardiovascular Med. 2021;22(3):779–86.
Boeddinghaus J, Nestelberger T, Twerenbold R, Koechlin L, Meier M, Troester V, et al. High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction. Clin Chem. 2019;65(7):893–904. https://doi.org/10.1373/clinchem.2018.300061.
Article CAS PubMed Google Scholar
Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet (London, England). 2022;399(10332):1347–58. https://doi.org/10.1016/s0140-6736(21)02391-6.
Cao G, Cai HX, Cao J. Advancement in Coronary Angiography or Percutaneous Coronary Intervention Using the Distal Transradial Artery Access in Acute Coronary Syndrome and Complex Coronary Artery Disease. Anatol J Cardiol. 2022;26(3):163–71. https://doi.org/10.5152/AnatolJCardiol.2021.933.
Article PubMed PubMed Central Google Scholar
Nohria R, Viera AJ. Acute Coronary Syndrome: Diagnosis and Initial Management. Am Fam Physician. 2024;109(1):34–42.
Sandoval Y, Apple FS, Mahler SA, Body R, Collinson PO, Jaffe AS. High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain. Circulation. 2022;146(7):569–81. https://doi.org/10.1161/circulationaha.122.059678.
Article CAS PubMed Google Scholar
Westwood M, van Asselt T, Ramaekers B, Whiting P, Thokala P, Joore M, et al. High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis. Health Technol Ass (Winchester, England). 2015;19(44):1–234. https://doi.org/10.3310/hta19440.
Aydin S, Ugur K, Aydin S, Sahin İ, Yardim M. Biomarkers in acute myocardial infarction: current perspectives. Vascular Health Risk Management. 2019;15:1–10. https://doi.org/10.2147/vhrm.S166157.
Article CAS PubMed PubMed Central Google Scholar
Jeong JH, Seo YH, Ahn JY, Kim KH, Seo JY, Chun KY, et al. Performance of Copeptin for Early Diagnosis of Acute Myocardial Infarction in an Emergency Department Setting. Ann Lab Med. 2020;40(1):7–14. https://doi.org/10.3343/alm.2020.40.1.7.
Article CAS PubMed Google Scholar
Tjora HL, Steiro OT, Langørgen J, Bjørneklett RO, Skadberg Ø, Bonarjee VVS, et al. Diagnostic Performance of Novel Troponin Algorithms for the Rule-Out of Non-ST-Elevation Acute Coronary Syndrome. Clin Chem. 2022;68(2):291–302. https://doi.org/10.1093/clinchem/hvab225.
Bhatt DL, Lopes RD, Harrington RA. Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA. 2022;327(7):662–75. https://doi.org/10.1001/jama.2022.0358.
Morgenthaler NG, Struck J, Jochberger S, Dünser MW. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab. 2008;19(2):43–9. https://doi.org/10.1016/j.tem.2007.11.001.
Article CAS PubMed Google Scholar
Schill F, Persson M, Engström G, Melander O, Enhörning S. Copeptin as a marker of atherosclerosis and arteriosclerosis. Atherosclerosis. 2021;338:64–8. https://doi.org/10.1016/j.atherosclerosis.2021.10.012.
Article CAS PubMed PubMed Central Google Scholar
Sarkarinejad A, Paydar S, Khosrojerdi A, Hosseini M. Copeptin: a novel prognostic biomarker in trauma: a review article. J Health Popul Nutr. 2023;42(1):128. https://doi.org/10.1186/s41043-023-00468-1.
Article PubMed PubMed Central Google Scholar
Slagman A, Searle J, Müller C, Möckel M. Temporal release pattern of copeptin and troponin T in patients with suspected acute coronary syndrome and spontaneous acute myocardial infarction. Clin Chem. 2015;61(10):1273–82. https://doi.org/10.1373/clinchem.2015.240580.
Article CAS PubMed Google Scholar
Schurtz G, Lamblin N, Bauters C, Goldstein P, Lemesle G. Copeptin in acute coronary syndromes and heart failure management: State of the art and future directions. Arch Cardiovasc Dis. 2015;108(6–7):398–407. https://doi.org/10.1016/j.acvd.2015.04.002.
Pintado MC, Maceda L, Trascasa M, Arribas I, De Pablo R. Prognostic tools at hospital arrival in acute myocardial infarction: copeptin and hepatocyte growth factor. Egyptian Heart J : (EHJ) : Official Bull Egyptian Soc Cardiol. 2022;74(1):35.
Gaber MA, Omar OHM, El-Deek SEM, Hassan AKM, Mahmoud MS, Meki AMA. Copeptin, miRNA-208, and miRNA-499 as New Biomarkers for Early Detection of Acute Coronary Syndrome. Appl Biochem Biotechnol. 2022;194(3):1193–205. https://doi.org/10.1007/s12010-021-03695-6.
Article CAS PubMed Google Scholar
Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;78(22):e187–285. https://doi.org/10.1016/j.jacc.2021.07.053.
Rampidis GP, Benetos G, Benz DC, Giannopoulos AA, Buechel RR. A guide for Gensini Score calculation. Atherosclerosis. 2019;287:181–3. https://doi.org/10.1016/j.atherosclerosis.2019.05.012.
Article CAS PubMed Google Scholar
Kabiri A, Gharin P, Forouzannia SA, Ahmadzadeh K, Miri R, Yousefifard M. HEART versus GRACE Score in Predicting the Outcomes of Patients with Acute Coronary Syndrome; a Systematic Review and Meta-Analysis. Arch Acad Emergency Med. 2023;11(1):e50. https://doi.org/10.22037/aaem.v11i1.2001.
Zhao YJ, Sun Y, Wang F, Cai YY, Alolga RN, Qi LW, et al. Comprehensive evaluation of time-varied outcomes for invasive and conservative strategies in patients with NSTE-ACS: a meta-analysis of randomized controlled trials. Frontiers Cardiovas Med. 2023;10:1197451. https://doi.org/10.3389/fcvm.2023.1197451.
Kite TA, Ladwiniec A, Arnold JR, McCann GP, Moss AJ. Early invasive versus non-invasive assessment in patients with suspected non-ST-elevation acute coronary syndrome. Heart (British Cardiac Society). 2022;108(7):500–6. https://doi.org/10.1136/heartjnl-2020-318778.
Article CAS PubMed Google Scholar
Bavishi C, Panwar SR, Dangas GD, Barman N, Hasan CM, Baber U, et al. Meta-Analysis of Radial Versus Femoral Access for Percutaneous Coronary Interventions in Non-ST-Segment Elevation Acute Coronary Syndrome. Am J Cardiol. 2016;117(2):172–8. https://doi.org/10.1016/j.amjcard.2015.10.039.
Noorayingarath H, Panjiyar BK, Gela I, Ramalingam L. Role of Cardiac Troponins in Predicting Adverse Outcomes in Acute Coronary Syndrome With Renal Dysfunction. Cureus. 2023;15(10):e47104. https://doi.org/10.7759/cureus.47104.
Article PubMed PubMed Central Google Scholar
Ahmed TAN, Johny JS, Abdel-Malek MY, Fouad DA. The additive value of copeptin for early diagnosis and prognosis of acute coronary syndromes. Am J Emerg Med. 2021;50:413–21. https://doi.org/10.1016/j.ajem.2021.08.069.
Szarpak L, Lapinski M, Gasecka A, Pruc M, Drela WL, Koda M, et al. Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients. Journal of cardiovascular development and disease. 2021;9(1). https://doi.org/10.3390/jcdd9010006.
Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315. https://doi.org/10.1093/eurheartj/ehv320.
Article CAS PubMed Google Scholar
Keller T, Tzikas S, Zeller T, Czyz E, Lillpopp L, Ojeda FM, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol. 2010;55(19):2096–106.
Comments (0)